Market Cap 18.27B
Revenue (ttm) 2.88B
Net Income (ttm) 1.20B
EPS (ttm) N/A
PE Ratio 15.80
Forward PE 15.24
Profit Margin 41.53%
Debt to Equity Ratio 0.00
Volume 626,400
Avg Vol 714,318
Day's Range N/A - N/A
Shares Out 45.11M
Stochastic %K 48%
Beta 0.62
Analysts Strong Sell
Price Target $468.83

Company Profile

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to d...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 301 608 9292
Address:
1000 Spring Street, Silver Spring, United States
clan
clan Sep. 13 at 10:22 AM
$MNKD ~ Mannkind Happenings to come ~ ~ 2025: 🌶FDA accepts SNDA Furoscix autoinjector 🌶Oct. - scPharma merger closing 🌶Inhale-1 results 🌶Oct - Teton 2 encore update 🌶Afrezza applic. submission for pregs 🌶Oct - FDA approval Afrezza dosing label 🌶Nintedanib Ph 2 trial initiated (IPF) 🌶Clofazimine trial fully enrolled 🌶Nov ~5th ISPAD conf (kids Afrezza) 🌶Nov ~7th Earnings 3Q25 release w/ record Revs 🌶2nd $UTHR molecule announced 🌶FDA accepts peds sBLA 🌶Afrezza ships to India 🌶Expanded Afrezza Sales force & campaign 🌶MNKD > $10/sh ~ Early 2026 ~ 🧀Afrezza rollout India 🧀ICON-1 (clofaz.) update 🧀Feb ~26th - 4Q25 Earnings w/ record Revs 🧀US Afrezza TRx > 1K/wk 🧀Mar - ATTD conference 🧀Mar - Oppenheimer conf. 🧀Teton 1 (US) results 🧀INHALE AID Ex trial results 🧀Clofaz. (ICON-1) readout 🧀May ~12th Earnings 1Q26 w/ record Revs 🧀2Q26 FDA approval kids Afrezza 🧀FDA approve Furoscix autoinjector . . .
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 13 at 5:48 AM
Enter: $UTHR OCT 17 2025 $410 CALLS Buy in Price: $17.10 - $19.40 Take Profit: $22.23 Stop Bleeding: $15.05 ROI Potential: 30% Exit Within: 16 Minutes https://moneygroup.us/alerts
0 · Reply
NolAsrtormZ
NolAsrtormZ Sep. 12 at 6:52 PM
$TC the last company that had been mid trial for iPf traded at 900 million market cap $PLRX put those #'s together w Gri trading at 5 million market cap. The last pay out was $UTHR for 5 Billion market cap jump Yet u guys go to China plays 🤣
0 · Reply
AdamURAtoFookingNeptune
AdamURAtoFookingNeptune Sep. 12 at 4:15 PM
$UTHR Holding up nicely 🌚
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Sep. 12 at 11:09 AM
$UTHR United Therapeutics To Showcase New Lung Disease Research At Major European Medical Conference
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 12 at 6:23 AM
Enter: $UTHR OCT 17 2025 $400 CALLS Buy in Price: $18.60 - $19.40 Take Profit: $25.22 Stop Bleeding: $17.07 ROI Potential: 30% Exit Within: 25 Minutes https://moneygroup.us/alerts
0 · Reply
NolAsrtormZ
NolAsrtormZ Sep. 11 at 7:34 PM
$GRI End of September for Top line iPF data $PLRX--- share some of that market cap $UTHR for iPf
0 · Reply
RunnerSignals
RunnerSignals Sep. 11 at 12:54 PM
Bulls on Parade! $UTHR $ORCL $PAHC $CF $IRM all strutting their stuff Watch the dance, not just the flash. https://stocksrunner.com/news/2025-09-11-daily-market-pulse-advanced-technical-analysis-and-stock-trading-strategies
0 · Reply
clan
clan Sep. 11 at 2:15 AM
$MNKD The pros knows. "Inflection point." 26in26 $SCPH $UTHR
1 · Reply
ZacksResearch
ZacksResearch Sep. 10 at 1:47 PM
$MNKD up 60% in a month — can the momentum keep running? 🚀 🔥 Pipeline is firing: Afrezza sBLA for pediatrics under FDA review, MNKD-101 Phase 3 ahead of schedule, MNKD-201 set for Phase 2 by year-end. 🤝 Expanded $UTHR collab adds another pulmonary hypertension therapy + $5M upfront + milestones + royalties. 💰 $360M acquisition of $SCPH brings FUROSCIX with a $10B U.S. market opportunity in CHF & CKD. Latest MNKD news here 👉 https://www.zacks.com/stock/quote/MNKD?q=MNKD&cid=sm-stocktwits-0-quote_overview-oc-11693&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_11693
0 · Reply
Latest News on UTHR
United Therapeutics: Is UTHR Stock Still A Buy At $400?

Sep 3, 2025, 10:10 AM EDT - 10 days ago

United Therapeutics: Is UTHR Stock Still A Buy At $400?


Why Is United Therapeutics Stock Rallying On Tuesday?

Sep 2, 2025, 10:59 AM EDT - 11 days ago

Why Is United Therapeutics Stock Rallying On Tuesday?


United Therapeutics: Don't Fear The Patent Expiration Too Much

Mar 29, 2025, 8:17 AM EDT - 6 months ago

United Therapeutics: Don't Fear The Patent Expiration Too Much


The Zen Ten - My Top Picks For 2025

Dec 29, 2024, 4:25 PM EST - 9 months ago

The Zen Ten - My Top Picks For 2025

AAPL BBW IBKR INTU META NVDA TSM


United Therapeutics: One To Believe In Despite Competitive Threats

Nov 14, 2024, 5:16 PM EST - 10 months ago

United Therapeutics: One To Believe In Despite Competitive Threats


United Therapeutics Shares Thrive

Aug 30, 2024, 12:02 PM EDT - 1 year ago

United Therapeutics Shares Thrive


United Therapeutics: Economics Support Compounding Ability

Aug 19, 2024, 10:00 PM EDT - 1 year ago

United Therapeutics: Economics Support Compounding Ability


clan
clan Sep. 13 at 10:22 AM
$MNKD ~ Mannkind Happenings to come ~ ~ 2025: 🌶FDA accepts SNDA Furoscix autoinjector 🌶Oct. - scPharma merger closing 🌶Inhale-1 results 🌶Oct - Teton 2 encore update 🌶Afrezza applic. submission for pregs 🌶Oct - FDA approval Afrezza dosing label 🌶Nintedanib Ph 2 trial initiated (IPF) 🌶Clofazimine trial fully enrolled 🌶Nov ~5th ISPAD conf (kids Afrezza) 🌶Nov ~7th Earnings 3Q25 release w/ record Revs 🌶2nd $UTHR molecule announced 🌶FDA accepts peds sBLA 🌶Afrezza ships to India 🌶Expanded Afrezza Sales force & campaign 🌶MNKD > $10/sh ~ Early 2026 ~ 🧀Afrezza rollout India 🧀ICON-1 (clofaz.) update 🧀Feb ~26th - 4Q25 Earnings w/ record Revs 🧀US Afrezza TRx > 1K/wk 🧀Mar - ATTD conference 🧀Mar - Oppenheimer conf. 🧀Teton 1 (US) results 🧀INHALE AID Ex trial results 🧀Clofaz. (ICON-1) readout 🧀May ~12th Earnings 1Q26 w/ record Revs 🧀2Q26 FDA approval kids Afrezza 🧀FDA approve Furoscix autoinjector . . .
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 13 at 5:48 AM
Enter: $UTHR OCT 17 2025 $410 CALLS Buy in Price: $17.10 - $19.40 Take Profit: $22.23 Stop Bleeding: $15.05 ROI Potential: 30% Exit Within: 16 Minutes https://moneygroup.us/alerts
0 · Reply
NolAsrtormZ
NolAsrtormZ Sep. 12 at 6:52 PM
$TC the last company that had been mid trial for iPf traded at 900 million market cap $PLRX put those #'s together w Gri trading at 5 million market cap. The last pay out was $UTHR for 5 Billion market cap jump Yet u guys go to China plays 🤣
0 · Reply
AdamURAtoFookingNeptune
AdamURAtoFookingNeptune Sep. 12 at 4:15 PM
$UTHR Holding up nicely 🌚
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Sep. 12 at 11:09 AM
$UTHR United Therapeutics To Showcase New Lung Disease Research At Major European Medical Conference
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 12 at 6:23 AM
Enter: $UTHR OCT 17 2025 $400 CALLS Buy in Price: $18.60 - $19.40 Take Profit: $25.22 Stop Bleeding: $17.07 ROI Potential: 30% Exit Within: 25 Minutes https://moneygroup.us/alerts
0 · Reply
NolAsrtormZ
NolAsrtormZ Sep. 11 at 7:34 PM
$GRI End of September for Top line iPF data $PLRX--- share some of that market cap $UTHR for iPf
0 · Reply
RunnerSignals
RunnerSignals Sep. 11 at 12:54 PM
Bulls on Parade! $UTHR $ORCL $PAHC $CF $IRM all strutting their stuff Watch the dance, not just the flash. https://stocksrunner.com/news/2025-09-11-daily-market-pulse-advanced-technical-analysis-and-stock-trading-strategies
0 · Reply
clan
clan Sep. 11 at 2:15 AM
$MNKD The pros knows. "Inflection point." 26in26 $SCPH $UTHR
1 · Reply
ZacksResearch
ZacksResearch Sep. 10 at 1:47 PM
$MNKD up 60% in a month — can the momentum keep running? 🚀 🔥 Pipeline is firing: Afrezza sBLA for pediatrics under FDA review, MNKD-101 Phase 3 ahead of schedule, MNKD-201 set for Phase 2 by year-end. 🤝 Expanded $UTHR collab adds another pulmonary hypertension therapy + $5M upfront + milestones + royalties. 💰 $360M acquisition of $SCPH brings FUROSCIX with a $10B U.S. market opportunity in CHF & CKD. Latest MNKD news here 👉 https://www.zacks.com/stock/quote/MNKD?q=MNKD&cid=sm-stocktwits-0-quote_overview-oc-11693&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_11693
0 · Reply
Kool_Aid_Mann
Kool_Aid_Mann Sep. 9 at 4:46 PM
$MNKD So $UTHR has rebounded right back over 400 to set new all time highs, but somehow we are stuck on the hamster wheel in the 5.50's. Could it have been Mike's crap SC deal? hmmm.
1 · Reply
highnihilism
highnihilism Sep. 9 at 4:09 PM
$UTHR Stock spiked 33% after a trial for Tyvaso in IPF showed lung function improvement. Wall Street responded with a round of upgraded ratings. #ETSY Etsy’s platform engagement & merchant growth are reinforcing the $72 level. Consumer-spending resilience (whimsy goth, fetish fashion, handmade crafts, domestic charm) #SG Sweetgreen’s luxury athleisure lifestyle setting: bright & clean interior, crisp greens, bright wooden textures (post-class vibe) is reinforcing the $18 level. Surrounded by the fresh & airy atmosphere & “glowing with a post-yoga sweat.“ #XHB Homebuilder demand trends & housing supply dynamics are reinforcing the $120 level. Fed rate-cut speculation & “golden cross” approaching. #BTC Bitcoin’s on-chain metrics & institutional flows are propping up the $112,000 level. Fed rate-cut speculation & “liquidity expansion.”
0 · Reply
kcphaeton
kcphaeton Sep. 8 at 8:29 PM
$MNKD $UTHR Kaboom! document details Form SC TO-T Filing Date 09/08/2025 Document Date 09/08/2025 Form Description Tender offer schedule and amendment filed by a third party. Filing Group Mergers & Acquisitions Company MannKind Corporation Issuer MANNKIND CORP
5 · Reply
Outcomes
Outcomes Sep. 8 at 7:26 PM
$MNKD $UTHR Teton....monumental.
1 · Reply
Michaelluh
Michaelluh Sep. 8 at 5:44 PM
$MNKD $UTHR Tune in today for the preview 😎.
0 · Reply
grampslol
grampslol Sep. 8 at 5:07 PM
$MNKD we mustn't forget that $LQDA Yutrepia DPI is already a big hit in the IPF market space and is crushing it in PAH. Poor tyvaso dpi behind the 8 ball. $UTHR #afizzle
1 · Reply
clan
clan Sep. 7 at 11:17 PM
$MNKD $UTHR 🚀👨‍🚀🌛🎶 https://youtu.be/8N3NC6gx-wg?si=X0eSPSgewUIocr-t Teton 2 - ✔️ Teton 1 - incoming Teton PPF - icing
0 · Reply
NolAsrtormZ
NolAsrtormZ Sep. 7 at 10:28 PM
$XBI $GRI bio Topline iPf trial results due soon. 3rd quarter 2025. We ALL KNOW HOW MUCH iPf data is worth🤑🤑🤑 $UTHR popped up 5 billion market cap on their iPf data. Gri $1.70 share 2.5 million share float Aprx. 4 million market cap
0 · Reply
BioTechHealthX
BioTechHealthX Sep. 7 at 4:48 PM
$UTHR Tyvaso DPI posted $315.2 million in sales, surging 22% YOY and solidifying United Therapeutics’ leadership in pulmonary hypertension. https://biotechhealthx.com/biotech-news/united-therapeutics-uthr-tyvaso-dpi-sales-hit-315-2m-up-22-yoy/
0 · Reply
clan
clan Sep. 7 at 4:12 PM
$MNKD @mangothegreat From my notes: ~ ~ Mannkind 2025 Happenings ~ ~ 🌶9/9 HC Wainwright conf. 11:30am 🌶9/9 Morgan Stanley conf. 2:35pm 🌶FDA accepts SNDA Furoscix autoinjector 🌶scPharma merger closing 🌶Inhale-1 (kids) results 🌶Affrezza applic. submission for pregs 🌶FDA approval Afrezza dosing label 🌶Nintedanib Ph 2 trial initiated (IPF) 🌶Clofazimine trial fully enrolled 🌶Nov ~5th ISPAD conf (kids Afrezza) 🌶Nov ~7th Earnings 3Q25 release w/ record Revs 🌶2nd $UTHR molecule announced 🌶FDA accepts pediatric sBLA 🌶Afrezza ships to India 🌶Expanded Afrezza Sales force and campaign 🌶MNKD > $10/sh ~ ~ Early 2026 ~ ~ 🧀Afrezza rollout India 🧀ICON-1 (clofaz.) update 🧀Feb ~26th Earnings 4Q25 Earnings w/ record Revs 🧀US Afrezza TRx > 1,000/wk 🧀ATTD conference (March) 🧀Teton 1 (US) results 🧀INHALE AID Ex trial results 🧀Clofaz. (ICON-1) readout 🧀May ~12th Earnings 1Q26 w/ record Revs 🧀FDA approves Afrezza for kids! . . .
0 · Reply
gigafactory
gigafactory Sep. 6 at 10:06 PM
$UTHR held only few shares. still worked out pretty well.
0 · Reply
clan
clan Sep. 6 at 4:38 PM
$MNKD 🦆🦆🦆🦆🦆🦆🦆🦆🦆🦆 A lot of ducks. $UTHR $SCPH
1 · Reply